UCP1 and Insulin resistance: Furthermore, we found that α‐CD, which inhibits UCP1 activity, can improve iWAT and skeletal muscle functions and alleviate insulin resistance in aging mice, suggesting a potential therapeutic strategy against aging‐associated sarcopenia and insulin resistance.